Fierce Pharma
OCTOBER 1, 2024
Johnson & Johnson is laying off 231 employees in New Jersey and Bayer is cutting 57 positions in the state, according to separate Worker Adjustment and Retraining Notification (WARN)
MedCity News
OCTOBER 1, 2024
CMS recently finalized the Patient Safety Structural Measure, which sets forth a broad roadmap for the implementation of a culture of safety, learning, transparency and accountability within hospitals and health systems nationwide — enabling and encouraging significant progress towards safer care and improved support for healthcare workers. The post Patient Safety Structural Measure Marks Progress Towards Safer and Compassionate Care appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 1, 2024
No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed this decade's ups and downs quite like Pfizer. As the company rolls ahead with a large restructuring campaign, some staffers in Ireland will soon feel the effects.
MedCity News
OCTOBER 1, 2024
Innovative approaches to home care will only be successful if organizations can ensure the safety of the professionals who enter patient homes. To do that, they’ll need to embrace new technologies that support in-home caregivers in real-time, and implement new protocols that ensure they are provided with the security and comfort they deserve. The post Staff Safety is Key to Sustaining Home Health Growth appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
OCTOBER 1, 2024
For the second time in 19 months, a federal judge in New York has dismissed a lawsuit claiming that Bristol Myers Squibb slow-walked its request for FDA approval of blood cancer drug Breyanzi to av | For the second time in 19 months, a federal judge in New York has dismissed a lawsuit claiming that Bristol Myers Squibb slow-walked its request for FDA approval of blood cancer drug Breyanzi to avoid paying $6.4 billion to Celgene shareholders in contingent value rights.
MedCity News
OCTOBER 1, 2024
Mental health company Lyra Health is now offering services for people struggling with cannabis, stimulants, opioids and nicotine. The post Lyra Health Expands Substance Use Disorder Support appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
OCTOBER 1, 2024
Autonomous coding startup Nym raised $47 million. The New York City-based company has 21 provider customers, including Geisinger and Ochsner Health. The post Nym Rakes In $47M for Autonomous Coding Engine appeared first on MedCity News.
Fierce Pharma
OCTOBER 1, 2024
Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of | Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today.
MedCity News
OCTOBER 1, 2024
Kailera Therapeutics licensed its portfolio of metabolic disorder drugs from Hengrui. The most advanced program has results from a Phase 2 test in China suggesting it could be competitive with other medications that target the GLP-1 and GIP receptors to trigger weight loss. The post Metabolic Meds Biotech Kailera Launches With $400M for Next-Generation Weight-Loss Drugs appeared first on MedCity News.
Fierce Pharma
OCTOBER 1, 2024
As the landscape of healthcare advertising evolves, how can brands effectively reach their audiences while ensuring da | Fierce Pharma’s Michelle Benz sought to find the answer to this pressing question, sitting down with Mallory Wils, EVP of Sales for healthcare data science advertising specialist BranchLab, during Digital Pharma East 2024.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Copyright Clearance Center
OCTOBER 1, 2024
October 1, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, will host “Let Licensing Bloom: The Root of Responsible AI” on 17 October, 3:00 – 4:00 pm CET at the 2024 Frankfurt Book Fair in Frankfurt Studio Hall 4.0, Room Europa. Panelists include Arend Kuester , CSIRO Publishing; Josh Jarrett , Wiley; Lui Simpson , Association of American Publishers (AAP); and Sarah Tegen , American Chemical Society (ACS).
Fierce Pharma
OCTOBER 1, 2024
In this interview, recorded live at Digital Pharma East, Kamya Elawadhi – Chief Client Officer at Doceree – discusses t | In this interview, recorded live at Digital Pharma East, Kamya Elawadhi – Chief Client Officer at Doceree – discusses the true essence of omnichannel marketing, emphasizing that it goes far beyond being just a buzzword.
Pharmaceutical Technology
OCTOBER 1, 2024
Otulfi is the fourth Stelara biosimilar approved in the US but will not launch until early 2025.
Fierce Pharma
OCTOBER 1, 2024
As digital advertising continues to evolve, Connected TV (CTV) and Over-the-Top (OTT) platforms remain essential for re | The world of pharma marketing is no exception to this. In today’s industry, professionals are tasked with managing the use of digital mediums alongside traditional media channels to create a cohesive marketing strategy.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PharmaTimes
OCTOBER 1, 2024
Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe
Fierce Pharma
OCTOBER 1, 2024
When it comes to pharma marketing in 2024, there is perhaps no bigger discussion than privacy. | When it comes to pharma marketing in 2024, there is perhaps no bigger discussion than privacy. From new state laws and regulations to growing consumer concerns, it is a topic that has remained on the very tip of the industry’s tongue.
European Pharmaceutical Review
OCTOBER 1, 2024
A paper has demonstrated a novel application of optimising processes to implement inverse design in pharmaceutical manufacturing. Machine learning techniques were assessed for use as a surrogate model to optimise a three-unit wet-granulation based flowsheet model for the manufacture of solid dosage forms. Dan et al. highlighted that recent research has begun to investigate the potential applications of deep learning in process development, however currently, use of this technique in this area
Fierce Pharma
OCTOBER 1, 2024
Join us for an exciting interview straight from Digital Pharma East 2024! | Join us for an exciting interview straight from Digital Pharma East 2024! Fierce Pharma’s Rebecca Willumson sits down with Chris Paquette, founder and CEO of DeepIntent, to delve into the pressing challenges, emerging trends, and exciting opportunities in healthcare marketing.
PharmaVoice
OCTOBER 1, 2024
Mark your calendars for the most important industry conferences in 2025.
Pharmaceutical Technology
OCTOBER 1, 2024
BioCryst Pharmaceuticals has received a contract valued at up to $69m from the US Department of Health and Human Services (HHS) for the procurement of RAPIVAB to treat influenza.
PharmExec
OCTOBER 1, 2024
Traci Miller (Director, Sonexus™ Access and Patient Support, Cardinal Health) discusses current digital trends in the patient services industry, as well as how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
Pharmaceutical Technology
OCTOBER 1, 2024
Ascendis Pharma has submitted a supplemental biologics licence application (sBLA) to the US Food and Drug Administration (FDA) for TransCon hGH to treat adults with growth hormone deficiency (GHD).
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmExec
OCTOBER 1, 2024
Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
Pharmaceutical Technology
OCTOBER 1, 2024
Aktis Oncology, a clinical-stage biotechnology company, has announced the successful closure of a $175m Series B financing round for advancing its radiopharmaceutical pipeline.
Pharma Marketing Network
OCTOBER 1, 2024
Pharma marketing strategies have evolved significantly over the years, adapting to changes in technology, regulatory landscapes, and consumer behavior. This article provides a comprehensive overview of the various facets of pharmaceutical marketing, from its historical evolution to future trends. By understanding these strategies, stakeholders in the pharmaceutical industry can better navigate the complexities of promoting their products effectively.
PharmExec
OCTOBER 1, 2024
Partnership is expected to leverage Amneal’s global manufacturing and product development experience and Metsera’s portfolio of ultra-long acting injectables and oral nutrient-stimulated hormone analogs.
PharmaTech
OCTOBER 1, 2024
Pharmaceutical Technology sat down with Anna Jenks, director of Pharmaceutical Operations for Merck & Co., Inc. in Rahway, NJ, USA to talk about her prologue presentation for AAPS PharmSci 360 2024.
PharmExec
OCTOBER 1, 2024
The application for Priority Review of Enhertu was supported by positive results from the DESTINY-Breast06 Phase III trial, which demonstrated that Enhertu reduced the risk of disease progression or death by 37% in patients with HER2-low or HER2-ultralow metastatic breast cancer.
Tribeca Knowledge
OCTOBER 1, 2024
M arket Access 2025, a new report from TRiBECA Knowledge, offers a fresh perspective on how the market access landscape for medicines continues to raise the bar for launch success and consistently better patient outcomes.
PharmExec
OCTOBER 1, 2024
Joseph Panetta, President and CEO of Biocom California, shares his insights on biotech industry trends, policy challenges, and educational initiatives, drawing from over 25 years of leadership in California’s thriving life sciences sector.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
338 
Let's personalize your content